Tolerance test of an oral nutrition supplement for kidney patients
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests how well kidney patients tolerate a new oral nutrition supplement taken by mouth or through a feeding tube. It aims to see if it is acceptable for daily use over 28 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can communicate clearly
- You have kidney disease or need extra protein as advised by a dietitian or doctor
- You are at risk of malnutrition or already malnourished
- You are expected to need the supplement for at least 28 days
- You do not have any planned tube feeding if choosing the neutral flavor
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a plant-based, high-energy, high-protein drink for people who are at medium or high risk of malnutrition. You would replace your current prescribed supplement with either a plant-based or dairy-based drink for 8 weeks to see how it affects your nutrition.
This study is testing a new nutritional drink or powder to see if children like it, tolerate it well, and can stick with it. It replaces your child's current supplement with a new one, and researchers will check how it affects their digestion and overall health.
This trial tests if a protein supplement during dialysis sessions can help people on maintenance dialysis maintain or improve their nutrition. It looks for participants who have been on dialysis for at least three months and are not severely malnourished.
This study tests if a special drink can improve nutrition and quality of life in people with chronic kidney disease (CKD) who are not on dialysis. It is for those who have lost weight or have poor appetite.
This study looks at how healthy adults digest a special nutritional drink. Researchers want to understand normal digestion to help improve care for people with feeding tubes.
This trial tests a special liquid supplement for patients with head, neck, lung, rectal, or esophageal cancer who are having radiation and are malnourished or at risk. The supplement is designed to be easier to digest if you have stomach or gut issues.
Hear when a new Disease Related Malnutrition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.